Statins share a dihydroxyheptanoic acid side chain assembled by condensation or organometallic chemistry. Dimethyl sulfoxide appears at three manufacturing roles across the class: reaction solvent for C–C bond formation, medium for amorphous solid dispersions, and recrystallization solvent for purification.
Rosuvastatin Side-Chain Condensation
Rosuvastatin calcium attaches its chiral dihydroxyheptenoate side chain by a Horner–Wadsworth–Emmons condensation between a pyrimidine aldehyde and a phosphonate. In DMSO, the phosphonate carbanion generated with NaH or LDA stays reactive while the poorly soluble pyrimidine aldehyde dissolves. The strong base is added to the phosphonate before the aldehyde, the reaction runs 40–90 °C under anhydrous conditions, and it favors the required E-isomer while the phosphate byproduct is removed in aqueous workup.
| API | Core | Key DMSO application |
|---|---|---|
| Rosuvastatin calcium | Substituted pyrimidine | HWE side-chain condensation, 40–90 °C |
| Atorvastatin calcium | Substituted pyrrole | Amorphous solid dispersion by lyophilization |
| Pitavastatin calcium | Cyclopropyl-quinoline | Recrystallization and purification |
| Fluvastatin | Indole | Side-chain nucleophilic substitution |
Table 1: DMSO applications across the major synthetic statin APIs
The Horner–Wadsworth–Emmons mechanism proceeds through deprotonation of the phosphonate by NaH or LDA to form a resonance-stabilized carbanion, which adds to the pyrimidine aldehyde to give a betaine intermediate that collapses with elimination of phosphate to form the E-alkene. DMSO’s role is to dissolve both the ionic base–phosphonate complex and the poorly soluble aldehyde in one phase, while its low proton availability prevents carbanion quenching. Anhydrous conditions below 0.1% water are specified because moisture destroys both NaH and the phosphonate carbanion.
DMSO is a Class 3 residual solvent under ICH Q3C with a recommended limit of 5000 ppm. Because all DMSO stages lie within the API chain, pharmaceutical-grade material is specified for every statin, and low water is additionally required for the strong-base rosuvastatin condensation so as not to quench sodium hydride or LDA.
Atorvastatin, Pitavastatin, and Fluvastatin
Atorvastatin calcium is marketed as an amorphous solid dispersion to improve dissolution; it is dissolved in DMSO and trapped by lyophilization or spray-drying, with secondary vacuum drying reducing residual solvent. Because the amorphous form is metastable, keeping residual DMSO low prevents the solvent from plasticizing the matrix and accelerating recrystallization. Pitavastatin uses DMSO as a recrystallization solvent, dissolving the statin hot and rejecting polar impurities on cooling, while fluvastatin uses DMSO for indole-intermediate side-chain substitutions and epoxide opening.
Why DMSO over DMF and NMP
DMSO dissolves both the strongly basic carbanion and the poorly soluble heteroaromatic core in a single phase, which DMF matches less reliably at these temperatures. Its 189 °C boiling point supports elevated recrystallization and condensation without pressure equipment. It is a Class 3 solvent under ICH Q3C, and USP <679>/EP 0429 pharmaceutical-grade material with low water is specified for the NaH-sensitive rosuvastatin step.
References
- Butler, D.E.; et al. U.S. Patent 5,273,995; Warner-Lambert/Pfizer, 1993.
- United States Pharmacopeia, Monograph <679> Dimethyl Sulfoxide; European Pharmacopoeia, Monograph 0429.
- ICH Harmonised Tripartite Guideline Q3C(R6), 2019.